Cytokine-induced endogenous procollagenase stored in the extracellular matrix of soft connective tissue results in a burst of collagen breakdown following its activation.
Numerous data strongly suggest the involvement of cytokines and the matrix metalloproteinase collagenase (MMP-1) in the pathogenesis of periodontitis. Recently, we have demonstrated that, upon culturing under the influence of IL-1 alpha + EGF, a large amount of inactive procollagenase (MMP-1) is stored in the extracellular matrix of periosteal tissue. We now show that this endogenous reservoir of proenzyme can be operative after activation with plasmin and is able to induce a rapid and almost complete breakdown of the collagenous extracellular matrix. The level of collagen degradation following activation showed a strong correlation with the amount of proenzyme that was incorporated in the tissue. The highest level of degradation (70% of the total amount of collagenous proteins) was found with the IL-1 alpha + EGF-treated explants, followed by those treated with IL-1 alpha alone (35%). Explants cultured with EGF or in the absence of cytokines, containing only small amounts of procollagenase, showed little collagen breakdown following plasmin activation (7%). Inhibition of metalloproteinases by EDTA, or blockage of plasmin by PMSF, prevented the degradation in all explants irrespective of the amount of proenzyme present in the tissue. Our findings demonstrate that endogenous proenzyme stored in a native connective tissue matrix can be activated at a later time interval which results in a massive breakdown of the tissue. This study shows a possible pathway of collagenase-induced breakdown without recent de novo synthesis of the enzyme. Such a sequence may be operative in chronic inflammatory diseases, such as periodontitis, where production of procollagenase under the influence of cytokines spans a longer time period, whereas breakdown is often characterized by a cyclic behaviour.
van der Zee
E
E
Department of Periodontology, Academic Centre for Dentistry, Amsterdam (ACTA), The Netherlands.
Everts
V
V
Beertsen
W
W
D000704:Analysis of Variance; D000818:Animals; D003094:Collagen / Q000378:metabolism*; D017364:Collagenases / Q000096:biosynthesis / Q000378:metabolism*; D003238:Connective Tissue / Q000201:enzymology; D046508:Culture Techniques; D016207:Cytokines / Q000502:physiology; D004789:Enzyme Activation; D004790:Enzyme Induction; D004792:Enzyme Precursors / Q000096:biosynthesis / Q000378:metabolism*; D004815:Epidermal Growth Factor / Q000494:pharmacology / Q000502:physiology; D005109:Extracellular Matrix / Q000201:enzymology*; D005341:Fibrinolysin / Q000378:metabolism; D006909:Hydroxyproline / Q000032:analysis; D007375:Interleukin-1 / Q000494:pharmacology / Q000502:physiology; D020781:Matrix Metalloproteinase 1; D010518:Periodontitis / Q000201:enzymology; D010521:Periosteum / Q000201:enzymology*; D011817:Rabbits; D011994:Recombinant Proteins / Q000494:pharmacology; D018709:Statistics, Nonparametric
D016207:Cytokines; D004792:Enzyme Precursors; D007375:Interleukin-1; D011994:Recombinant Proteins; D004815:Epidermal Growth Factor; D003094:Collagen; D005341:Fibrinolysin; D017364:Collagenases; C022440:procollagenase; D020781:Matrix Metalloproteinase 1; D006909:Hydroxyproline